Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Merck (MRK) - Get Report : "I'm not a buyer of Merck, I prefer Eli Lilly (LLY) - Get Report or Abbott Laboratories (ABT) - Get Report ."

Phillips 66 (PSX) - Get Report : "They are well run and can create real value there."

Five Below (FIVE) - Get Report : "I've always believed in this one. They own this business."

Cintas (CTAS) - Get Report : "This is one of my absolute favorites. They are terrific operators."

Cramer and the AAP team are pouncing on the recent weakness in Raytheon (RTN) - Get Report . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

On Real Money, Cramer says the pajama traders had better get with the program. Get more of Cramer's insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in RTN,LLY, ABT.